Assignment of Assignor's Interest

Recorded: 2025-02-10 Pages: 6

Assignor

TABUTEAU, HERRIOT

Executed: 2025-02-04

Assignee

ANTECIP BIOVENTURES II LLC

630 FIFTH AVENUE, SUITE 2000, NEW YORK, NEW YORK, 10111

Covered Properties (13)

Compounds and Combinations Thereof for Treating Neurological and Psychiatric Conditions

Application: 63/715,455 →

Compounds and Combinations Thereof for Treating Neurological and Psychiatric Conditions

Application: 63/715,485 →

Compounds and Combinations Thereof for Treating Neurological and Psychiatric Conditions

Application: 18/942,141 →

Publication: US US20250064797A1

Pharmaceutical Dosage Forms for Treating Neurological and Psychiatric Conditions

Application: 63/719,699 →

Compounds and Combinations Thereof for Treating Neurological and Psychiatric Conditions

Application: 18/952,791 →

Publication: US US20250073188A1

Compounds and Combinations Thereof for Treating Neurological and Psychiatric Conditions

Application: 63/725,482 →

Bupropion as a Modulator of Drug Activity

Application: 18/967,488 →

Publication: US US20250205223A1

Bupropion as a Modulator of Drug Activity

Application: 18/968,681 →

Compounds and Combinations Thereof for Treating Neurological and Psychiatric Conditions

Application: 18/974,091 →

Publication: US US20250241874A1

Treatment of Poor Metabolizers of Dextromethorphan with a Combination of Bupropion and Dextromethorphan

Application: 18/986,390 →

Publication: US US20250262172A1

Bupropion Dosage Forms with Reduced Food and Alcohol Dosing Effects

Application: 18/988,447 →

Publication: US US20250262202A1

Bupropion as a Modulator of Drug Activity

Application: 63/740,232 →

Compounds and Combinations Thereof for Treating Neurological and Psychiatric Conditions

Application: 19/005,998 →

Publication: US US20250268889A1